You are viewing: France Laboratory Filtration Market analysis
Part of: Laboratory Filtration Market (Global)

The France Laboratory Filtration Market was valued at $115.2 Million in 2024 and projected to reach to $173.2 Million by 2029, representing a compound annual growth rate of 8.5%. France's laboratory filtration market is poised for sustained expansion through 2029, driven by the country's robust pharmaceutical sector and commitment to life sciences innovation.

France Laboratory Filtration Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Laboratory Filtration Market Trends and Insights

  • This 8.5% compound annual growth rate reflects France's strong investment in healthcare infrastructure and pharmaceutical research capabilities.
  • France's position as a leading European life sciences hub drives demand for advanced filtration technologies across clinical laboratories, research institutions, and diagnostic centers. The French market benefits from stringent regulatory standards and a well-established quality control framework that necessitates high-performance filtration solutions.
  • France's pharmaceutical and biotechnology sectors continue to adopt innovative filtration systems to meet evolving compliance requirements and improve operational efficiency.
  • Between 2024 and 2029, France is expected to see increased adoption of membrane filtration and sterile filtration technologies, supported by government initiatives promoting healthcare modernization and research advancement..

Key Market Statistics

  • CAGR (2024-2029) 8.5% CAGR
  • Market Size, 2024 ~USD 115.2 Million
  • Forecast, 2029 ~USD 173.2 Million
  • Country France

France Laboratory Filtration Market Overview

Market Valuation :

France's laboratory filtration market is valued at USD 115.2 million in 2024, with strong growth trajectory positioning it as a key European market segment within the broader healthcare filtration landscape.

Growth Momentum :

The French market is expanding at an 8.5% CAGR through 2029, outpacing the global average of 8.3%, driven by increased pharmaceutical R&D investments and stringent quality standards in life sciences.

Life Sciences Hub Status :

France's established position as a leading European life sciences and pharmaceutical research center generates sustained demand for advanced filtration technologies across academic, clinical, and industrial laboratories.

Healthcare Infrastructure Investment :

Continued government and private sector investment in French healthcare infrastructure and modernization of laboratory facilities supports robust adoption of innovative filtration solutions.

France Laboratory Filtration Market Dynamics

  • The projected growth from USD 115.2 million to USD 173.2 million reflects increasing demand for high-performance filtration systems across research institutions, hospitals, and biopharmaceutical manufacturers.
  • France's regulatory environment and quality standards necessitate advanced filtration technologies, creating consistent market opportunities. Key growth catalysts include rising investments in biotech research, expansion of contract research organizations (CROs), and modernization of laboratory infrastructure.
  • The French government's support for life sciences clusters and R&D initiatives further strengthens market fundamentals.
  • As pharmaceutical companies and research institutions prioritize contamination control and product quality, demand for specialized filtration solutions will continue to accelerate, positioning France as a strategic market within Europe's healthcare filtration landscape..

Market Ecosystem

logo-mobile

LABORATORY FILTRATION MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Pfizer researchers collaborated with Pennsylvania State University to evaluate commercial 0.2/0.22 µm sterilizing-grade membrane filters for a four-serotype glycoconjugate vaccine formulation. The study compared single-layer and dual-layer membranes to assess filtration capacity, membrane fouling, and prefiltration effectiveness. The highly asymmetric Millipore Express membrane demonstrated substantially higher filtration capacity than more homogeneous membranes. Its supporting structure acted as an internal prefilter, reducing fouling of the selective membrane layer and providing insights into improving sterile filtration performance.
company logo
Regeneron researchers evaluated PES membrane filters in small-scale sterile filtration studies involving concentrated monoclonal antibody formulations. The study compared pleated and non-pleated membrane configurations to assess polysorbate 80 adsorption-related analytical responses, potential leachable, and filter-flushing performance. The study demonstrated differences between pleated and non-pleated PES membrane configurations. A secondary analytical peak appeared with the pleated filter but not the non-pleated configuration, highlighting limitations in small-scale model selection and the importance of representative filters for process development.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • France's laboratory filtration market is valued at USD 115.2 million in 2024 and will reach USD 173.2 million by 2029, representing 50% growth over five years.
    • France maintains an 8.5% CAGR, outpacing the global average of 8.3%, driven by strong pharmaceutical and biotech sectors.
    • Stringent EU regulatory standards and France's commitment to healthcare quality drive adoption of advanced filtration technologies.
    • France's life sciences infrastructure and research institutions create sustained demand for laboratory filtration solutions through 2029.

    Laboratory Filtration Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment MEMBRANE FILTERS (Type)
    Forecast Period 2024–2029
    Growth Rate CAGR of 8.3% from 2024 to 2029
    Largest Segment FILTERS & FILTER MEDIA (Product)
    Market Size Base Year (Billions) ~USD 4.09 (2024)
    Revenue Forecast (Billions) ~USD 6.1 (2029)
    Segments Covered Product, Type, Material

    France Laboratory Filtration Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Filters & Filter Media
    • Filtration Accessories
    • Filtration Assemblies

    By Type

    • Capsule Filters
    • Depth Filters
    • Filter Dispensers
    • Filter Flasks
    • Filter Funnels
    • Filter Holders
    • Filter Housings
    • Filter Media
    • Membrane Filters
    • Membrane Sheets & Discs
    • Microfiltration Assemblies
    • Mixed Cellulose Ester & Cellulose Acetate (Mce & Ca)
    • Nanofiltration Assemblies
    • Nylon
    • Other Filters
    • Other Filtration Accessories
    • Other Filtration Assemblies
    • Other Filtration Membranes
    • Other Membrane Filters
    • Polycarbonate Track-Etched (Pcte)
    • Polyethersulfone (Pes)
    • Polytetrafluoroethylene (Ptfe)
    • Polyvinylidene Difluoride (Pvdf)
    • Seals
    • Syringe Filters
    • Syringeless Filters
    • Ultrafiltration Assemblies
    • Vacuum Pumps

    By Material

    • Filtration Media
    • Filtration Membranes

    FRANCE: LABORATORY FILTRATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES23.624.826.428.230.332.635.137.97.5
    HOSPITALS & CLINICAL LABORATORIES1010.410.911.512.31313.914.86.3
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES111.2117.9126.4136.2147.5159.9173.7189.18.4
    TOTAL144.8153.2163.7175.9190205.5222.7241.88.1

    Target Audience

    • Pharmaceutical Manufacturers : French and international pharma companies operating in France need market sizing and growth forecasts to plan filtration technology investments, optimize supply chains, and ensure compliance with local quality standards.
    • Laboratory Equipment Suppliers : Filtration equipment manufacturers and distributors require France-specific market data to develop localized sales strategies, identify customer segments, and forecast revenue opportunities in this growing European market.
    • Research & Academic Institutions : French universities, research centers, and CROs need market intelligence to understand filtration technology trends, benchmark procurement practices, and align laboratory modernization initiatives with market developments.
    • Healthcare Facility Managers : Hospital laboratory directors and facility managers in France require market insights to evaluate filtration solutions, justify capital expenditures, and ensure alignment with healthcare infrastructure modernization initiatives.
    • Investment & Strategy Consultants : Private equity firms, management consultants, and business strategists need France-specific market data to assess investment opportunities, evaluate market attractiveness, and develop growth strategies for healthcare sector clients.

    Key Companies in the France Laboratory Filtration Market

    CompanyHQOwnershipStrongest segments
    ALLERGAN PLCIrelandPrivate CompanyMedical aesthetics and dermatology,Eye care,Neuroscience and CNS,
    TECHNICOLOR SAFrancePublic CompanyBroadband CPE (fiber gateways, routers, extenders, Wi-Fi XL, FWA including Falcon 5G),Video CPE (set-top boxes, dongles, smart media devices, media servers),Software, Platforms, and Service Management (navigate, HomeSight, service management solutions),
    GENERAL ELECTRICUnited StatesPublic CompanyCommercial Engines & OE Sales,Commercial MRO & Spare Parts,Defense & Propulsion OE,
    GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
    MERCK KGAAGermanyPublic CompanyLife Science (tools, reagents, bioprocessing, CDMO),Healthcare (oncology, neurology, fertility, rare diseases),Electronics (semiconductor and display materials, gases, equipment),
    DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and bioproduction solutions),Life Sciences (research tools, genomic and analytical systems),Diagnostics (clinical instruments, consumables, software, services),
    SARTORIUS AGGermanyPublic CompanyBioprocess solutions (bioreactors, fermenters, filtration, process chromatography, fluid management),Lab products and services (lab filtration, water systems, weighing, pipettes, microbiological testing, OEM),Advanced analytical and cell-based solutions (BLI, cytometry, live-cell imaging, SPR, cell selection, microtissue),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    3M COMPANYUnited StatesPublic CompanySafety and Industrial,Transportation and Electronics,Consumer,
    AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
    EATON CORPORATION PLCIrelandPublic CompanyElectrical Americas,Electrical Global,Aerospace,
    GEA GROUPGermanyPublic CompanySeparation & Flow Technologies (separators, decanters, valves, pumps),Liquid & Power Technologies (brewing, liquid processing, thermal, carbon capture),Food & Health Technologies (meat, poultry, vegan, pharma processing),
    AVANTOR, INC.United StatesPublic CompanyMaterials and consumables,Equipment and instrumentation,Services and specialty procurements,
    STERIS PLCUnited StatesPublic CompanyHealthcare (hospitals and providers),Applied Sterilization Technologies (contract sterilization),Life Sciences (pharma and biopharma solutions),
    AHLSTROMFinlandPrivate CompanyFiltration and Life Sciences,Food and Consumer Packaging,Protective and Industrial Materials,
    GVS S.P.A.ItalyPublic CompanyHealthcare & Life Sciences Filtration,Health & Safety PPE and Industrial Filtration,Energy & Mobility Components,

    ALLERGAN PLC

    Allergan PLC is an Ireland-based private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and specialty healthcare sectors.

    TECHNICOLOR SA

    Technicolor SA is a French public company established in 1985 with 1,552 employees. The company provides media and entertainment technology services.

    GENERAL ELECTRIC

    General Electric is a United States-based public company founded in 1892 with 57,000 employees. The company operates across multiple industrial and technology sectors.

    GE HEALTHCARE

    GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees. The company provides healthcare technology and medical imaging solutions.

    MERCK KGAA

    Merck KGaA is a German public company with roots dating back to 1668 and 59,077 employees. The company operates in pharmaceuticals, life sciences, and performance materials.

    DANAHER CORPORATION

    Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. The company operates across diagnostics, life sciences, and environmental solutions.

    SARTORIUS AG

    Sartorius AG is a German public company founded in 1870 with 14,242 employees. The company specializes in laboratory and bioprocess technologies.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company is a global leader in life sciences, analytical instruments, and laboratory services.

    3M COMPANY

    3M Company is a United States-based public company founded in 1902 with 60,500 employees. The company manufactures diversified products across industrial, healthcare, safety, and consumer segments.

    AGILENT TECHNOLOGIES, INC.

    Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. The company provides analytical instruments, software, and services for life sciences and diagnostics.

    EATON CORPORATION PLC

    Eaton Corporation PLC is an Ireland-based public company founded in 1911 with 97,303 employees. The company operates in electrical, hydraulic, and industrial power management solutions.

    GEA GROUP

    GEA Group is a German public company founded in 1881 with 19,670 employees. The company provides process technology and equipment for the food, beverage, and pharmaceutical industries.

    AVANTOR, INC.

    Avantor, Inc. is a United States-based public company founded in 1904 with 13,500 employees. The company supplies specialty chemicals, materials, and equipment for research and manufacturing.

    STERIS PLC

    Steris PLC is a United States-based public company founded in 1985 with 17,937 employees. The company provides sterilization, contamination control, and surgical support solutions.

    AHLSTROM

    Ahlstrom is a Finland-based private company founded in 1851 with 6,883 employees. The company produces fiber-based materials for various industrial applications.

    GVS S.P.A.

    GVS S.P.A. is an Italy-based public company founded in 1979 with 3,952 employees. The company manufactures filtration and separation products for healthcare and industrial markets.

    Reasons to Buy this Report

    • Market-Specific Sizing & Forecasts : Access precise valuation data for France's laboratory filtration market (USD 115.2M in 2024, USD 173.2M by 2029) with country-specific CAGR analysis to inform investment and expansion decisions.
    • Competitive Positioning Intelligence : Understand France's market dynamics relative to global trends (8.5% vs. 8.3% global CAGR) to identify competitive advantages and market entry strategies specific to French pharmaceutical and research sectors.
    • Regulatory & Infrastructure Insights : Gain detailed understanding of France's healthcare infrastructure investments, quality standards, and regulatory requirements driving filtration technology adoption across laboratories and manufacturing facilities.
    • Sector-Specific Growth Drivers : Identify key growth catalysts unique to France including biotech cluster expansion, CRO growth, and government R&D initiatives to prioritize sales and marketing efforts effectively.
    • Strategic Decision Support : Leverage France-focused market intelligence for product development, partnership strategies, and resource allocation decisions within one of Europe's most dynamic life sciences markets.

    Frequently asked questions

    What is the current size of France's laboratory filtration market?

    France's laboratory filtration market was valued at USD 115.2 million in 2024 and is projected to grow to USD 173.2 million by 2029.

    What is the growth rate for laboratory filtration in France?

    France's laboratory filtration market is growing at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2029.

    What drives demand for laboratory filtration products in France?

    Demand in France is driven by stringent EU regulatory standards, a robust pharmaceutical and biotech sector, and France's commitment to healthcare quality and modernization.

    Which filtration technologies are most adopted in France?

    France shows increasing adoption of membrane filtration and sterile filtration technologies, particularly in pharmaceutical manufacturing and clinical laboratory applications.

    How does France's market growth compare to global trends?

    France's 8.5% CAGR slightly exceeds the global average of 8.3%, reflecting the country's strong life sciences infrastructure and healthcare investment.

    RESEARCH METHODOLOGY

    This study relied heavily on secondary sources, directories, and databases to identify and collect information for analyzing the global laboratory filtration market. The study conducted in-depth interviews with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the laboratory filtration market. The secondary sources used for this study include the International Association of Laboratory Schools (IALS), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), National Science Foundation (NSF), American Society for Clinical Laboratory Science (ASCLS), American Filtration and Separations Society (AFS), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), Canadian Association for Laboratory Accreditation (CALA), American Membrane Technology Associations (AMTA), European Membrane Society (EMS), National Center for Biotechnology Information (NCBI), Food and Drug Administration (FDA), European Medicines Agency (EMA), Health Canada, World Health Organization (WHO), International Society for Pharmaceutical Engineering (ISPE), BioPlan Associates, Eurostat, Factiva; corporate & regulatory filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, laboratory filtration practices, biopharmaceutical manufacturing trends, and technological perspectives.

    Primary Research

    We conducted in-depth interviews with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at key market players, and industry consultants, among others, to gather and validate critical qualitative and quantitative information and assess the market's prospects. We interviewed various primary sources from both the supply and demand sides of the market to gather qualitative and quantitative information. The following is a breakdown of the primary respondents:

    Laboratory Filtration Market 
 Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the laboratory filtration market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:

    Laboratory Filtration Market Top Down and Bottom Up Approach

    Data Triangulation

    After estimating the market size as described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain accurate statistics for all segments and subsegments, we employed data triangulation and market breakdown procedures where applicable. We triangulated the data by examining factors and trends from both the demand and supply sides.

    Market Definition

    Laboratory filtration refers to the separation of solid particles from liquids or gases using a filter medium in a controlled laboratory setting. Laboratory filtration products include filters & filter media, filtration assemblies, and filtration accessories used for laboratory-scale physical and chemical processes. This market includes laboratory filtration products that are utilized by pharmaceutical & biopharmaceutical companies, academic & research institutes, and hospitals & diagnostic laboratories.

    This report covers laboratory filtration products used for separation, clarification, purification, and sterile filtration. These include membrane filters, membrane sheets and discs, filter media, depth filters, filtration assemblies, and filtration accessories used across research, sample preparation, analytical testing, and biopharmaceutical manufacturing.

    Key Stakeholders

    • Laboratory filtration equipment and accessory manufacturing companies
    • Laboratory filtration equipment and accessory distributors
    • Pharmaceutical and biotechnology companies
    • Hospitals and clinical laboratories
    • Academic and research institutes
    • Life science companies
    • Market research and consulting firms
    • Venture capitalists and investors
    • Contract research organizations (CROs)
    • Government organizations
    • Private research firms

    Report Objectives

    • To define, describe, and forecast the laboratory filtration market based on product, material, technique, type, end user, and region
    • To provide detailed information regarding the factors influencing market growth such as drivers, opportunities, restraints, and challenges
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall laboratory filtration market
    • To analyze key market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To profile the key players in the global laboratory filtration market, as well as comprehensively analyze their core competencies and market rankings
    • To forecast the size of the market segments for six regions: North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East (GCC and Rest of Middle East), and Africa
    • To analyze competitive developments, such as product launches, expansions, acquisitions, partnerships, collaborations, and agreements in the laboratory filtration market
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategies

    Available customizations:

    Based on the market data provided, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:

    Portfolio Assessment

    • Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).

    Geographical Analysis

    • A further breakdown of the Rest of Europe laboratory filtration market, by country
    • A further breakdown of the Rest of Asia Pacific laboratory filtration market, by country
    • A further breakdown of the Rest of Latin America laboratory filtration market, by country

     

    Get the Full Laboratory Filtration Market Report

    Full forecast, segment splits, and company analysis for all Laboratory Filtration Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status